ERBB2 and breast cancer: Studies suggest that the clinicopathologic features of breast cancer in Arab patients vary from those seen in the Western patient population and are characterized by early onset of disease, more advanced stage, higher rate of HER2 amplification, and possibly a different somatic mutational profile.